Your browser doesn't support javascript.
loading
Therapeutic Administration of a Monoclonal Anti-Il-1ß Antibody Protects Against Experimental Melioidosis.
Weehuizen, Tassili A F; Lankelma, Jacqueline M; De Jong, Hanna K; De Boer, Onno J; Roelofs, Joris J T H; Day, Nicholas P; Gram, Hermann; De Vos, Alex F; Wiersinga, W Joost.
Affiliation
  • Weehuizen TA; *Center for Infection and Immunity Amsterdam (CINIMA)/Center for Experimental and Molecular Medicine (CEMM), Academic Medical Center, Amsterdam, The Netherlands †Department of Pathology, Academic Medical Center, Amsterdam, The Netherlands ‡Mahidol-Oxford Tropical Medicine Research Unit, Faculty of Tropical Medicine, Mahidol University, Bangkok, Thailand §Centre for Tropical Medicine and Global Health, Nuffield Department of Clinical Medicine, University of Oxford, Oxford, UK ||Novartis Institute
Shock ; 46(5): 566-574, 2016 11.
Article in En | MEDLINE | ID: mdl-27219859

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Interleukin-1beta / Melioidosis / Antibodies, Monoclonal Limits: Adolescent / Adult / Aged / Animals / Humans / Middle aged Language: En Journal: Shock Journal subject: ANGIOLOGIA / CARDIOLOGIA Year: 2016 Document type: Article

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Interleukin-1beta / Melioidosis / Antibodies, Monoclonal Limits: Adolescent / Adult / Aged / Animals / Humans / Middle aged Language: En Journal: Shock Journal subject: ANGIOLOGIA / CARDIOLOGIA Year: 2016 Document type: Article